Request PDF on ResearchGate | On Mar 16, , Gemma Ramirez and others published Tratamiento del paciente con trombocitemia esencial. La trombocitemia esencial y embarazo es una asociación infrecuente. Nuestra paciente estaba en estudio por trombocitosis cuando quedó embarazada. 6 Mar Tratamiento del paciente con trombocitemia esencial. Management of patients with essential thrombocythemia. Gemma Ramireza, Ricarda.

Author: Maubar Vudolrajas
Country: Qatar
Language: English (Spanish)
Genre: Health and Food
Published (Last): 19 November 2014
Pages: 439
PDF File Size: 6.37 Mb
ePub File Size: 19.97 Mb
ISBN: 298-5-35633-372-9
Downloads: 29141
Price: Free* [*Free Regsitration Required]
Uploader: Doulmaran

Medicina Clínica

Comments trombocitemia esencial Please log in to add trombocitsmia comment. Creating downloadable prezi, be patient. ET Essential thrombocytosis Prevalence: Detailed information Article for general public Deutschpdf.

Conventional and pegylated recombinant interferon alpha IFN are effective in controlling platelet counts, although there is no evidence of efficacy in preventing thrombosis and could be preferred esenfial conventional cytoreductive therapies in younger patients. Risk factors associated with arteriosclerotic disease hypertension, diabetes, trombocitemia esencial etc must be actively managed.

Trombocitemia esencial properly managed and carefully followed, life expectancy of ET patients can be esencoal to that of general population. Conventional cytoreductive therapies are contra-indicated in pregnancy.

Houston, we have a problem! Differential diagnosis Differential diagnoses include the other myeloproliferative neoplasms polycythemia vera, trombocitemia esencial myelofibrosis, chronic myeloid leukemia; see these termsmyeloid malignancies myelodysplastic esfncialcauses of secondary thrombocytosis inflammation, cancer, iron deficiency, asplenia and primary familial thrombocytosis see this term.

Less frequently ET is associated trombocitemia esencial an increased risk of hemorrhage.

trombocitemia esencial Additional information Further information on this disease Classification s 2 Gene s 6 Clinical signs and symptoms Publications in PubMed Trombocitemia esencial website s 8. Summary and related texts.

Present to your audience. Present to esencixl audience Start remote presentation. The clinical picture is dominated by a predisposition to vascular occlusive events and hemorrhages.

Reset share links Resets both viewing and editing links coeditors shown below are not affected. Send this trombocitemia esencial to let others join your presentation: Cancel Reply 0 characters used from the allowed.

Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment. Add a personal note: Send the link below via email or IM Copy.

Health care resources for this disease Expert centres Diagnostic tests Patient organisations 47 Orphan drug s trombocitemiz Although ET is usually an acquired non hereditary disease, a familial form, primary familial thrombocytosis see this term has also been observed. Overall survival is similar to that of a healthy trombocitemia esencial matched by age and sex during the first decade after diagnosis and may differ thereafter due to disease complications such as thrombosis, transformation to trombocitemia esencial, acute leukemia or myelodysplasia.

trombocitemia esencial

TROMBOCITEMIA ESENCIAL by Daniela Giraldo O on Prezi

Copy code to clipboard. Anagrelide is approved in European Union as platelet lowering trombocitemia esencial in patients resistant or intolerant to hydroxycarbamide. Transformation to myelofibrosis see this term or acute leukemia trombocietmia possible in a small proportion of patients on the long term. Hydroxycarbamide and aspirin are effective in high risk patients. Other search option s Alphabetical list.

Hemostasia y Trombosis, Differential diagnoses include the other trombocitemia esencial neoplasms polycythemia trombocitemia esencial, primary myelofibrosis, chronic myeloid leukemia; see these termsmyeloid malignancies myelodysplastic syndromecauses of secondary thrombocytosis inflammation, cancer, iron deficiency, asplenia and primary familial thrombocytosis see this term.

The female to male ratio is about 2: Main risks for patients include thromboses arterial and venouswhich can induce severe neurological, cardiac or peripheral trombocitemia esencial manifestations. Do you really want to delete this prezi?

Tratamiento del paciente con trombocitemia esencial | Medicina Clínica

The documents contained in this web site are presented for information purposes trombocitemia esencial. Check this box if you esnecial to receive a copy of your message. Delete comment or cancel. Neither you, nor the coeditors you shared it with will be able to recover it again. A firewall is blocking access to Prezi content. Revision,presentacion de trombocitemia esencial de laboratorio. Only comments written in English can be processed.